Inventor · disambiguated record
David Urech
Also filed as: URECH DAVID · URECH DAVID M
48 granted patents·24 pending applications·327 citations·filing 2003–2022
98Inventor score
Top patents by PatentIndex Score
72 records- 0197US9090684B2Stable and soluble antibodies inhibiting VEGFESBATECH ALCON BIOMED RES UNIT·Filed 2012·Granted Jul 28, 2015·54 cites·8 claims
- 0296US8293235B2Humanization of rabbit antibodies using a universal antibody frameworkBORRAS LEONARDO·Filed 2009·Granted Oct 23, 2012·49 cites·16 claims
- 0395US8673310B2Stable and soluble antibodies inhibiting TNFαBORRAS LEONARDO·Filed 2009·Granted Mar 18, 2014·36 cites·12 claims
- 0495US8349322B2Stable and soluble antibodies inhibiting VEGFESBATECH ALCON BIOMED RES UNIT·Filed 2009·Granted Jan 8, 2013·31 cites·10 claims
- 0593US10590193B2Stable and soluble antibodies inhibiting VEGFESBATECH ALCON BIOMED RES UNIT·Filed 2017·Granted Mar 17, 2020·9 cites·14 claims
- 0693US9873737B2Stable and soluble antibodies inhibiting VEGFESBATECH ALCON BIOMED RES UNIT·Filed 2015·Granted Jan 23, 2018·10 cites·7 claims
- 0792US8067547B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2006·Granted Nov 29, 2011·21 cites·41 claims
- 0891US9422366B2Stable and soluble antibodies inhibiting TNF alphaESBATECH ALCON BIOMED RES UNIT·Filed 2013·Granted Aug 23, 2016·12 cites·24 claims
- 0991US8937162B2Humanization of rabbit antibodies using a universal antibody frameworkBORRAS LEONARDO·Filed 2012·Granted Jan 20, 2015·14 cites·8 claims
- 1090US10100111B2Stable and soluble antibodies inhibiting TNF alphaESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Oct 16, 2018·7 cites·21 claims
- 1190US8227199B2Methods for identifying immunobinders of cell-surface antigensURECH DAVID·Filed 2010·Granted Jul 24, 2012·10 cites·22 claims
- 1289US10087244B2Humanization of rabbit antibodies using a universal antibody frameworkESBATECH ALCON BIOMED RES UNIT·Filed 2015·Granted Oct 2, 2018·6 cites·2 claims
- 1388US9593161B2Humanization of rabbit antibodies using a universal antibody frameworkESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Mar 14, 2017·7 cites·19 claims
- 1488US8697074B2Methods and compositions for enhanced delivery of macromoleculesHULMANN-COTTIER VALERIE·Filed 2009·Granted Apr 15, 2014·24 cites·15 claims
- 1584US10570198B2Stable and soluble antibodiesNOVARTIS AG·Filed 2016·Granted Feb 25, 2020·3 cites·5 claims
- 1683US8796425B2Method for decreasing immunogenicityURECH DAVID·Filed 2010·Granted Aug 5, 2014·3 cites·3 claims
- 1782US9803027B2Method for decreasing immunogenicityESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Oct 31, 2017·2 cites·2 claims
- 1882US9221905B2Methods for producing immunobinders of cell-surface antigensESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Dec 29, 2015·2 cites·16 claims
- 1982US8545849B2Stable and soluble antibodiesBORRAS LEONARDO JOSE·Filed 2011·Granted Oct 1, 2013·7 cites·8 claims
- 2080US9683034B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Jun 20, 2017·2 cites·19 claims
- 2180US9556265B2Solubility optimization of immunobindersBORRAS LEONARDO·Filed 2009·Granted Jan 31, 2017·3 cites·5 claims
- 2280US8465937B2Methods for identifying B-clones which bind cell-surface antigensURECH DAVID·Filed 2012·Granted Jun 18, 2013·2 cites·18 claims
- 2379US8280711B2Sequence based engineering and optimization of single chain antibodiesURECH DAVID M·Filed 2008·Granted Oct 2, 2012·3 cites·14 claims
- 2477US9598487B2Stable and soluble antibodiesESBATECH ALCON BIOMED RES UNIT·Filed 2013·Granted Mar 21, 2017·2 cites·5 claims
- 2575US9908940B2Humanized immunobinders of cell-surface antigensESBATECH ALCON BIOMED RES UNIT·Filed 2015·Granted Mar 6, 2018·1 cites·16 claims
- 2674US10077312B2CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseasesNUMAB AG·Filed 2014·Granted Sep 18, 2018·3 cites·18 claims
- 2774US2019382498A1Humanized immunobinders of cell-surface antigensNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2874US2023212265A1Novel antibody frameworksNumab Therapeutics AG·Filed 2022·Application pending·0 cites
- 2973US11319371B2Anti-CD3 antibodiesNumab Therapeutics AG·Filed 2018·Granted May 3, 2022·1 cites·16 claims
- 3073US11236150B2Hetero-dimeric multi-specific antibody formatNumab Therapeutics AG·Filed 2016·Granted Feb 1, 2022·1 cites·17 claims
- 3173US10174102B2Antibody frameworksNUMAB INNOVATION AG·Filed 2014·Granted Jan 8, 2019·1 cites·12 claims
- 3272US11046757B2Solubility optimization of immunobindersNOVARTIS AG·Filed 2019·Granted Jun 29, 2021·0 cites·4 claims
- 3370US9371525B2Functionalized polypeptidesESBATECH ALCON BIOMED RES UNIT·Filed 2013·Granted Jun 21, 2016·0 cites·17 claims
- 3470US8936785B2scFv antibodies which pass epithelial and/or endothelial layersAUF DER MAUR ADRIAN·Filed 2007·Granted Jan 20, 2015·1 cites·3 claims
- 3570US2020172608A1Stable and soluble antibodies inhibiting vegfNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3670US2021214461A1Method for decreasing immunogenicityNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3769US8637022B2Functionalized polypeptidesURECH DAVID·Filed 2009·Granted Jan 28, 2014·0 cites·13 claims
- 3868US11879005B2Hetero-dimeric multi-specific antibody formatNumab Therapeutics AG·Filed 2022·Granted Jan 23, 2024·0 cites·17 claims
- 3968US11578123B2Stable and soluble antibodies inhibiting TNFαNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·0 cites·17 claims
- 4067US11858981B2Humanization of rabbit antibodies using a universal antibody frameworkNOVARTIS AG·Filed 2017·Granted Jan 2, 2024·0 cites·19 claims
- 4166US11427628B2Antibody frameworksNumab Therapeutics AG·Filed 2018·Granted Aug 30, 2022·0 cites·4 claims
- 4266US10781268B2Method for decreasing immunogenicityNOVARTIS AG·Filed 2017·Granted Sep 22, 2020·0 cites·5 claims
- 4365US2018142028A1Methods for identifying immunobinders of cell-surface antigensESBATECH ALCON BIOMED RES UNIT·Filed 2018·Application pending·0 cites
- 4463US9315572B2Stable and soluble antibodies inhibiting TNF alphaESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Apr 19, 2016·0 cites·18 claims
- 4563US2023242651A1Stable antibody variable domain framework combinationsNumab Therapeutics AG·Filed 2022·Application pending·0 cites
- 4662US2022403028A1Novel anti-cd3 antibodiesNumab Therapeutics AG·Filed 2022·Application pending·0 cites
- 4761US8691228B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2012·Granted Apr 8, 2014·0 cites·20 claims
- 4861US2012288878A1Methods for identifying immunobinders of cell-surface antigensURECH DAVID·Filed 2012·Application pending·0 cites
- 4959US8389693B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2011·Granted Mar 5, 2013·0 cites·7 claims
- 5057US10221237B2Solubility optimization of immunobindersESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Mar 5, 2019·0 cites·11 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →